Regeneron Pharmaceuticals and Bayer HealthCare report 2-year data from VISTA-DME trial Feb. 11, 2014 No Comments
Researchers report data from phase I/II study of retinal gene therapy in patients with choroideremia Feb. 10, 2014 No Comments
Regenera to conduct phase II trial of RPh-201 in treatment of ischemic optic neuropathy Feb. 6, 2014 No Comments
Aerie begins dosing in phase IIb study of combination product for glaucoma or ocular hypertension Feb. 3, 2014 No Comments
Adenovir Pharma initiates phase II study of antiviral drug for infectious eye disease Jan. 28, 2014 No Comments
Novartis synthesizes new agents for macular degeneration and other disorders Jan. 21, 2014 No Comments
RSS